Figure 2From: Weekly induction intraperitoneal chemotherapy after primary surgical cytoreduction in patients with advanced epithelial ovarian cancerOverall survival by IP therapy and residual disease after primary surgery. IP therapy vs. without IP therapy in patients with residual disease > 1 cm (HR = 0.69, P = 0.02) (A) and residual disease ≤ 1 cm (HR = 0.73, P = 0.09) (B), respectivelyBack to article page